The role of Vimentin intermediate filaments in the progression of lung cancer

American Journal of Respiratory Cell and Molecular Biology

Volumn 50, Issue 1, 2014, Pages 1-6

  Kidd, Martha E ^a,b   Shumaker, Dale K ^b   Ridge, Karen M ^b  

^a Northwestern University   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Epithelial to mesenchymal transition; Invadopodia; Lung cancer; Metastatic cascade; Vimentin

Indexed keywords

BECLIN 1; HYPOXIA INDUCIBLE FACTOR 1; VIMENTIN;

CANCER CELL; CANCER GROWTH; CANCER SURVIVAL; CELL CYCLE REGULATION; CELL INVASION; CELL MIGRATION; CELL MOTILITY; CELL ORGANELLE; EPITHELIAL MESENCHYMAL TRANSITION; HUMAN; INTERMEDIATE FILAMENT; INTRACELLULAR SIGNALING; LUNG CANCER; REVIEW; SIGNAL TRANSDUCTION;

CARCINOGENESIS; DISEASE PROGRESSION; EPITHELIAL-MESENCHYMAL TRANSITION; HUMANS; INTERMEDIATE FILAMENTS; LUNG NEOPLASMS; VIMENTIN;

EID: 84891775571     PISSN: 10441549     EISSN: 15354989     Source Type: Journal    
DOI: 10.1165/rcmb.2013-0314TR     Document Type: Review

References (50)

1. Barberis L, Pasquali C, Bertschy-Meier D, Cuccurullo A, Costa C, Ambrogio C, Vilbois F, Chiarle R, Wymann M, Altruda F, et al. Leukocyte transmigration is modulated by chemokine-mediated PI3Kg-dependent phosphorylation of vimentin. Eur J Immunol 2009; 39: 1136-1146.
2. Tzivion G, Luo Z-J, Avruch J. Calyculin A-induced vimentin phosphorylation sequesters 14-3-3 and displaces other 14-3-3 partners in vivo. J Biol Chem 2000; 275: 29772-29778. (Pubitemid 32043861)
3. Satelli A, Li S. Vimentin in cancer and its potential as a molecular target for cancer therapy. Cell Mol Life Sci 2011; 68: 3033-3046.
4. Fuchs E, Weber K. Intermediate filaments: structure, dynamics, function and disease. Annu Rev Biochem 1994; 63: 345-382.
5. Steinert PM, Marekov LN, Fraser RD, Parry DA. Keratin intermediate filament structure: crosslinking studies yield quantitative information on molecular dimensions and mechanism of assembly. J Mol Biol 1993; 230: 436-452. (Pubitemid 23161354)
6. McKeon FD, Kirschner MW, Caput D. Homologies in both primary and secondary structure between nuclear envelope and intermediate filament proteins. Nature 1986; 319: 463-468. (Pubitemid 16212925)
7. Steinert PM. Structure, function, and dynamics of keratin intermediate filaments. J Invest Dermatol 1993; 100: 729-734. (Pubitemid 23151229)
8. Crystal RG, Randell SH, Engelhardt JF, Voynow J, Sunday ME. Airway epithelial cells: current concepts and challenges. Proc Am Thorac Soc 2008; 5: 772-777.
9. Dubey S, Powell CA. Update in lung cancer 2008. Am J Respir Crit Care Med 2009; 179: 860-868.
10. Sutherland KD, Berns A. Cell of origin of lung cancer. Mol Oncol 2010; 4: 397-403.
11. Hammerschmidt S, Wirtz H. Lung cancer: current diagnosis and treatment. Dtsch Arztebl Int 2009; 106: 809-818, quiz 819-820.
12. Non-small cell lung cancer survival rates by stage [Internet]. Atlanta: American Cancer Society, Inc.; 2012 [updated 2013 July 12; accessed 2013 July 28]. Available from: http://www.cancer.org/cancer/lungcancer-non-smallcell/ detailedguide/non-small-cell-lungcancer-survival-rates
13. Geiger TR, Peeper DS. Metastasis mechanisms. Biochim Biophys Acta 2009; 1796: 293-308.
14. Eriksson JE, Dechat T, Grin B, Helfand B, Mendez M, Pallari HM, Goldman RD. Introducing intermediate filaments: from discovery to disease. J Clin Invest 2009; 119: 1763-1771.
15. Heron-Milhavet L, Khouya N, Fernandez A, Lamb NJ. Akt1 and Akt2: differentiating the aktion. Histol Histopathol 2011; 26: 651-662.
16. Gardino AK, Yaffe MB. 14-3-3 proteins as signaling integration points for cell cycle control and apoptosis. Semin Cell Dev Biol 2011; 22: 688-695.
17. Aitken A. Post-translational modification of 14-3-3 isoforms and regulation of cellular function. Semin Cell Dev Biol 2011; 22: 673-680.
18. Eijkelenboom A, Burgering BM. FoxOs: signalling integrators for homeostasis maintenance. Nat Rev Mol Cell Biol 2013; 14: 83-97.
19. Dobson M, Ramakrishnan G, Ma S, Kaplun L, Balan V, Fridman R, Tzivion G. Bimodal regulation of FoxO3 by Akt and 14-3-3. Biochim Biophys Acta 2011; 1813: 1453-1464.
20. Zhu QS, Rosenblatt K, Huang KL, Lahat G, Brobey R, Bolshakov S, Nguyen T, Ding Z, Belousov R, Bill K, et al. Vimentin is a novel Akt1 target mediating motility and invasion. Oncogene 2011; 30: 457-470.
21. Sivaramakrishnan S, Schneider JL, Sitikov A, Goldman RD, Ridge KM. Shear stress induced reorganization of the keratin intermediate filament network requires phosphorylation by protein kinase C z. Mol Biol Cell 2009; 20: 2755-2765.
22. Phua DCY, Humbert PO, Hunziker W. Vimentin regulates scribble activity by protecting it from proteasomal degradation. Mol Biol Cell 2009; 20: 2841-2855.
23. Vuoriluoto K, Haugen H, Kiviluoto S, Mpindi J-P, Nevo J, Gjerdrum C, Tiron C, Lorens JB, Ivaska J. Vimentin regulates EMT induction by slug and oncogenic H-Ras and migration by governing AXL expression in breast cancer. Oncogene 2011; 30: 1436-1448.
24. Maxwell SA, Cherry EM, Bayless KJ. Akt, 14-3-3zeta, and vimentin mediate a drug-resistant invasive phenotype in diffuse large B-cell lymphoma. Leuk Lymphoma 2011; 52: 849-864.
25. Wang RC, Wei Y, An Z, Zou Z, Xiao G, Bhagat G, White M, Reichelt J, Levine B. Akt-mediated regulation of autophagy and tumorigenesis through beclin 1 phosphorylation. Science 2012; 338: 956-959.
26. Perlson E, Michaelevski I, Kowalsman N, Ben-Yaakov K, Shaked M, Seger R, Eisenstein M, Fainzilber M. Vimentin binding to phosphorylated Erk sterically hinders enzymatic dephosphorylation of the kinase. J Mol Biol 2006; 364: 938-944. (Pubitemid 44765042)
27. Yang JY, Zong CS, Xia W, Yamaguchi H, Ding Q, Xie X, Lang JY, Lai CC, Chang CJ, Huang WC, et al. Erk promotes tumorigenesis by inhibiting FoxO3a via MDM2-mediated degradation. Nat Cell Biol 2008; 10: 138-148. (Pubitemid 351194043)
28. Xing H, Zhang S, Weinheimer C, Kovacs A, Muslin AJ. 14-3-3 proteins block apoptosis and differentially regulate MAPK cascades. EMBO J 2000; 19: 349-358. (Pubitemid 30072605)
29. Thiery JP. Epithelial-mesenchymal transitions in tumour progression. Nat Rev Cancer 2002; 2: 442-454.
30. Valastyan S, Weinberg RA. Tumor metastasis: molecular insights and evolving paradigms. Cell 2011; 147: 275-292.
31. Schoumacher M, Goldman RD, Louvard D, Vignjevic DM. Actin, microtubules, and vimentin intermediate filaments cooperate for elongation of invadopodia. J Cell Biol 2010; 189: 541-556.
32. Helfand BT, Mendez MG, Murthy SN, Shumaker DK, Grin B, Mahammad S, Aebi U, Wedig T, Wu YI, Hahn KM, et al. Vimentin organization modulates the formation of lamellipodia. Mol Biol Cell 2011; 22: 1274-1289.
33. Gilles C, Polette M, Zahm JM, Tournier JM, Volders L, Foidart JM, Birembaut P. Vimentin contributes to human mammary epithelial cell migration. J Cell Sci 1999; 112: 4615-4625. (Pubitemid 30034810)
34. Hu L, Lau SH, Tzang CH, Wen JM, Wang W, Xie D, Huang M, Wang Y, Wu MC, Huang JF, et al. Association of vimentin overexpression and hepatocellular carcinoma metastasis. Oncogene 2004; 23: 298-302. (Pubitemid 38142264)
35. Rittling SR, Baserga R. Functional analysis and growth factor regulation of the human vimentin promoter. Mol Cell Biol 1987; 7: 3908-3915.
36. Rittling SR, Coutinho L, Amram T, Kolbe M. AP-1/Jun binding sites mediate serum inducibility of the human vimentin promoter. Nucleic Acids Res 1989; 17: 1619-1633. (Pubitemid 19065134)
37. Lilienbaum A, Paulin D. Activation of the human vimentin gene by the tax human T-cell leukemia virus. I. Mechanisms of regulation by the NF-kappa b transcription factor. J Biol Chem 1993; 268: 2180-2188. (Pubitemid 23033631)
38. Rogel MR, Soni PN, Troken JR, Sitikov A, Trejo HE, Ridge KM. Vimentin is sufficient and required for wound repair and remodeling in alveolar epithelial cells. FASEB J 2011; 25: 3873-3883.
39. Wu Y, Zhang X, Salmon M, Lin X, Zehner ZE. TGFbeta1 regulation of vimentin gene expression during differentiation of the C2C12 skeletal myogenic cell line requires Smads, AP-1 and SP1 family members. Biochim Biophys Acta 2007; 1773: 427-439. (Pubitemid 46275072)
40. Krishnamachary B, Berg-Dixon S, Kelly B, Agani F, Feldser D, Ferreira G, Iyer N, LaRusch J, Pak B, Taghavi P, et al. Regulation of colon carcinoma cell invasion by hypoxia-inducible factor 1. Cancer Res 2003; 63: 1138-1143. (Pubitemid 36278449)
41. Erler JT, Weaver VM. Three-dimensional context regulation of metastasis. Clin Exp Metastasis 2009; 26: 35-49.
42. Adam SA, Gerace L. Cytosolic proteins that specifically bind nuclear location signals are receptors for nuclear import. Cell 1991; 66: 837-847. (Pubitemid 121001719)
43. Eriksson JE, He T, Trejo-Skalli AV, Harmala-Brasken AS, Hellman J, Chou YH, Goldman RD. Specific in vivo phosphorylation sites determine the assembly dynamics of vimentin intermediate filaments. J Cell Sci 2004; 117: 919-932. (Pubitemid 38386949)
44. Liu T, Guevara OE, Warburton RR, Hill NS, Gaestel M, Kayyali US. Regulation of vimentin intermediate filaments in endothelial cells by hypoxia. Am J Physiol Cell Physiol 2010; 299: C363-C373.
45. Tang DD, Bai Y, Gunst SJ. Silencing of p21-activated kinase attenuates vimentin phosphorylation on Ser-56 and reorientation of the vimentin network during stimulation of smooth muscle cells by 5-hydroxytryptamine. Biochem J 2005; 388: 773-783. (Pubitemid 40941563)
46. Ivaska J, Pallari HM, Nevo J, Eriksson JE. Novel functions of vimentin in cell adhesion, migration, and signaling. Exp Cell Res 2007; 313: 2050-2062. (Pubitemid 46842979)
47. Bowden ET, Onikoyi E, Slack R, Myoui A, Yoneda T, Yamada KM, Mueller SC. Co-localization of cortactin and phosphotyrosine identifies active invadopodia in human breast cancer cells. Exp Cell Res 2006; 312: 1240-1253.
48. Weaver AM. Invadopodia: specialized cell structures for cancer invasion. Clin Exp Metastasis 2006; 23: 97-105. (Pubitemid 44440169)
49. Paccione RJ, Miyazaki H, Patel V, Waseem A, Gutkind JS, Zehner ZE, Yeudall WA. Keratin down-regulation in vimentin-positive cancer cells is reversible by vimentin RNA interference, which inhibits growth and motility. Mol Cancer Ther 2008; 7: 2894-2903.
50. Le Clainche C, Carlier M. Regulation of actin assembly associated with protrusion and adhesion in cell migration. Physiol Rev 2008; 88: 489-513. (Pubitemid 351520086)